Exogenesis Brings in $3.7M

Xconomy Boston — 

Exogenesis, a Billerica, MA-based biotech startup, has raised $3.7 million of a $4.1 million equity offering, according to an SEC filing. Members of Inflection Point Ventures and Venture Capital Fund of New England are listed as directors on the filing for the funding. Exogenesis, founded in 2005, develops what it calls “gas cluster ion beam technology,” for improving the surfaces of implantable medical devices.